| Expression and regulation of growth-regulated oncogene alpha in human endometrial stromal cells. | endometrial, |
| Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi s sarcoma. | sarcoma, |
| Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer. | oral |
| The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. | ovarian, |
| Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression. | gastric, |
| Seminal plasma induces angiogenic chemokine expression in cervical cancer cells and regulates vascular function. | cervical, |
| Expression and production of the CXC chemokine growth-related oncogene-alpha by human eosinophils. | None |
| IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation. | None |
| Increased circulating concentrations of growth-related oncogene (GRO)-alpha in patients with inflammatory bowel disease. | None |
| Vitamin D3 oppositely regulated the expression of Growth-related oncogene-alpha in THP-1 cells in vitro and human primary monocytes ex vivo via different intracellular signal pathways. | None |
| Seminal plasma rapidly enhanced the expression of the angiogenic chemokines, interleukin (IL)-8 and growth regulated oncogene alpha (GRO) in HeLa cells. | None |
| The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. | None |